Endoglycosidase [EPC]

Endoglycosidase [EPC] was reported 1853 times

These side effects are most commonly reported by patients taking drugs of the Endoglycosidase [EPC] class:

# Drug class Count
0 OFF LABEL USE 1535
1 NO ADVERSE EVENT 1064
2 DIARRHOEA 909
3 FATIGUE 861
4 RASH 666
5 PAIN 591
6 ASTHENIA 537
7 PYREXIA 515
8 DYSPNOEA 501
9 NAUSEA 494
10 HEADACHE 463
11 DIZZINESS 449
12 MALAISE 445
13 PRURITUS 439
14 VOMITING 435
15 ARTHRALGIA 428
16 DECREASED APPETITE 401
17 INJECTION SITE PAIN 397
18 INFUSION RELATED REACTION 387
19 ALOPECIA 366
20 DRUG INEFFECTIVE 364
21 HYPERTENSION 358
22 HYPOAESTHESIA 357
23 HYPERSENSITIVITY 352
24 ABDOMINAL DISCOMFORT 347
25 DEATH 344
26 CONTUSION 341
27 NASOPHARYNGITIS 330
28 SWELLING 327
29 PNEUMONIA 321
30 STOMATITIS 316
31 CONDITION AGGRAVATED 308
32 DISCOMFORT 308
33 ABDOMINAL PAIN UPPER 307
34 HEPATIC ENZYME INCREASED 301
35 WEIGHT DECREASED 301
36 CONFUSIONAL STATE 300
37 ANXIETY 296
38 CHEST PAIN 294
39 PERIPHERAL SWELLING 292
40 MUSCLE SPASMS 291
41 SINUSITIS 288
42 DRUG HYPERSENSITIVITY 287
43 ASTHMA 286
44 INFECTION 285
45 URTICARIA 281
46 BLOOD CHOLESTEROL INCREASED 280
47 INSOMNIA 279
48 PARAESTHESIA 279
49 PAIN IN EXTREMITY 275
50 GASTROINTESTINAL DISORDER 273
51 WEIGHT INCREASED 273
52 BLISTER 271
53 GENERAL PHYSICAL HEALTH DETERIORATION 270
54 ARTHROPATHY 269
55 HELICOBACTER INFECTION 268
56 AUTOIMMUNE DISORDER 265
57 LOWER RESPIRATORY TRACT INFECTION 265
58 PRODUCT DOSE OMISSION ISSUE 264
59 DUODENAL ULCER PERFORATION 262
60 INJECTION SITE REACTION 258
61 MOBILITY DECREASED 256
62 DRY MOUTH 255
63 ILL-DEFINED DISORDER 255
64 FOLLICULITIS 254
65 TYPE 2 DIABETES MELLITUS 254
66 MATERNAL EXPOSURE DURING PREGNANCY 251
67 HAND DEFORMITY 248
68 SYSTEMIC LUPUS ERYTHEMATOSUS 246
69 BURSITIS 245
70 FIBROMYALGIA 244
71 MUSCULAR WEAKNESS 244
72 ROAD TRAFFIC ACCIDENT 244
73 JOINT SWELLING 243
74 RHEUMATOID ARTHRITIS 242
75 GLOSSODYNIA 241
76 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 240
77 C-REACTIVE PROTEIN ABNORMAL 240
78 MUSCULOSKELETAL STIFFNESS 240
79 DEEP VEIN THROMBOSIS POSTOPERATIVE 239
80 IMPAIRED HEALING 237
81 OSTEOARTHRITIS 236
82 LIVER DISORDER 234
83 LUNG DISORDER 232
84 LOWER LIMB FRACTURE 230
85 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 229
86 MUSCLE INJURY 228
87 PERICARDITIS 226
88 WOUND 226
89 MUSCULOSKELETAL PAIN 225
90 PEMPHIGUS 224
91 SCIATICA 223
92 MEMORY IMPAIRMENT 220
93 RHEUMATIC FEVER 219
94 OEDEMA 216
95 PSORIATIC ARTHROPATHY 216
96 SYNOVITIS 216
97 WHEEZING 215
98 IRRITABLE BOWEL SYNDROME 213
99 LIP DRY 213
100 NEUROPATHY PERIPHERAL 213
101 NIGHT SWEATS 213
102 DEPRESSION 212
103 JOINT RANGE OF MOTION DECREASED 209
104 LIVER INJURY 208
105 INFLAMMATION 207
106 INJURY 207
107 FACET JOINT SYNDROME 205
108 SWOLLEN JOINT COUNT INCREASED 204
109 RHEUMATOID FACTOR POSITIVE 202
110 PERIPHERAL VENOUS DISEASE 200
111 OBESITY 199
112 ERYTHEMA 197
113 GAIT DISTURBANCE 193
114 DISEASE PROGRESSION 188
115 ABDOMINAL PAIN 185
116 RECTAL HAEMORRHAGE 181
117 AMNESIA 179
118 DELIRIUM 179
119 DRUG INTOLERANCE 179
120 INJECTION SITE ERYTHEMA 179
121 OEDEMA PERIPHERAL 178
122 INTENTIONAL PRODUCT USE ISSUE 175
123 MIGRAINE 173
124 PRODUCT USE ISSUE 168
125 VISUAL IMPAIRMENT 167
126 GAIT INABILITY 166
127 WOUND INFECTION 166
128 DYSPEPSIA 164
129 CROHN^S DISEASE 162
130 WHITE BLOOD CELL COUNT INCREASED 162
131 ARTHRITIS 161
132 COLITIS ULCERATIVE 161
133 PULMONARY FIBROSIS 160
134 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 158
135 BREAST CANCER STAGE III 157
136 X-RAY ABNORMAL 154
137 FEELING HOT 152
138 HEPATIC CIRRHOSIS 150
139 GRIP STRENGTH DECREASED 146
140 DISLOCATION OF VERTEBRA 145
141 EAR INFECTION 143
142 PANCREATITIS 143
143 RESPIRATORY DISORDER 143
144 BACK PAIN 142
145 BONE EROSION 142
146 FREQUENT BOWEL MOVEMENTS 142
147 CHILLS 140
148 RETINITIS 140
149 LUPUS-LIKE SYNDROME 138
150 CONSTIPATION 136
151 LUPUS VULGARIS 136
152 PORPHYRIA ACUTE 136
153 SLEEP DISORDER 136
154 HYPERCHOLESTEROLAEMIA 135
155 EXOSTOSIS 133
156 NEUTROPENIA 132
157 LARYNGITIS 131
158 LABORATORY TEST ABNORMAL 130
159 OSTEOPOROSIS 130
160 ADVERSE EVENT 129
161 FOOT DEFORMITY 129
162 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 129
163 WHITE BLOOD CELL COUNT DECREASED 129
164 C-REACTIVE PROTEIN INCREASED 127
165 COUGH 125
166 KNEE ARTHROPLASTY 123
167 PRODUCT USE IN UNAPPROVED INDICATION 122
168 HIP ARTHROPLASTY 121
169 PRESCRIBED OVERDOSE 121
170 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 120
171 PREGNANCY 118
172 PLATELET COUNT DECREASED 114
173 URINARY TRACT INFECTION 113
174 TREATMENT FAILURE 112
175 GRIP STRENGTH 107
176 HYPOTENSION 107
177 CONTRAINDICATED PRODUCT ADMINISTERED 105
178 ADVERSE DRUG REACTION 104
179 MYALGIA 104
180 THERAPY NON-RESPONDER 104
181 FALL 101
182 COVID-19 98
183 THERAPEUTIC PRODUCT EFFECT DECREASED 96
184 JOINT STIFFNESS 95
185 PRODUCT STORAGE ERROR 95
186 DRUG TOLERANCE DECREASED 92
187 PLASMA CELL MYELOMA 92
188 RED BLOOD CELL SEDIMENTATION RATE INCREASED 90
189 THROMBOCYTOPENIA 89
190 C-REACTIVE PROTEIN 87
191 MYELOSUPPRESSION 87
192 ANAEMIA 86
193 WALKING AID USER 86
194 HAEMOGLOBIN DECREASED 84
195 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 84
196 MEDICATION ERROR 83
197 MATERNAL EXPOSURE TIMING UNSPECIFIED 82
198 SURGERY 82
199 HOSPITALISATION 81
200 JOINT DISLOCATION 81
201 TREMOR 81
202 ILLNESS 75
203 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 75
204 MYASTHENIA GRAVIS 70
205 LOSS OF CONSCIOUSNESS 69
206 INTERCEPTED PRODUCT STORAGE ERROR 66
207 WEIGHT FLUCTUATION 65
208 CONGENITAL ANOMALY 63
209 METASTASES TO CENTRAL NERVOUS SYSTEM 63
210 EXPOSURE DURING PREGNANCY 62
211 SWOLLEN JOINT COUNT 62
212 VISION BLURRED 62
213 TACHYCARDIA 61
214 EJECTION FRACTION DECREASED 59
215 FEELING ABNORMAL 57
216 INJECTION SITE SWELLING 57
217 SOMNOLENCE 57
218 DEHYDRATION 56
219 LIVE BIRTH 55
220 PRESCRIBED UNDERDOSE 55
221 SYNCOPE 55
222 BURNING SENSATION 53
223 INJECTION SITE BRUISING 53
224 NEUTROPHIL COUNT DECREASED 52
225 OXYGEN SATURATION DECREASED 52
226 UPPER RESPIRATORY TRACT INFECTION 52
227 BLOOD CREATININE INCREASED 51
228 HYPOKALAEMIA 51
229 INJECTION SITE RASH 51
230 MALIGNANT NEOPLASM PROGRESSION 51
231 NECK PAIN 51
232 SEPSIS 51
233 CHEST DISCOMFORT 50
234 IMMUNODEFICIENCY 50
235 BALANCE DISORDER 49
236 DRY SKIN 49
237 GASTROOESOPHAGEAL REFLUX DISEASE 49
238 EAR PAIN 48
239 ABDOMINAL DISTENSION 46
240 ACUTE KIDNEY INJURY 46
241 UNDERDOSE 46
242 FLUSHING 45
243 INFLUENZA 45
244 BLOOD PRESSURE INCREASED 44
245 BRAIN FOG 44
246 CARDIAC DISORDER 44
247 EPISTAXIS 44
248 ADMINISTRATION SITE PAIN 43
249 ATRIAL FIBRILLATION 43
250 BLOOD GLUCOSE INCREASED 43
251 FEBRILE NEUTROPENIA 43
252 BRONCHITIS 42
253 CELLULITIS 42
254 INTERSTITIAL LUNG DISEASE 42
255 RHINORRHOEA 42
256 TASTE DISORDER 42
257 RASH PRURITIC 41
258 SKIN DISCOLOURATION 41
259 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 40
260 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 40
261 PALPITATIONS 39
262 BLOOD PRESSURE DECREASED 38
263 LEUKOPENIA 38
264 PRODUCT QUALITY ISSUE 38
265 DYSPHAGIA 37
266 MASTECTOMY 37
267 NEOPLASM MALIGNANT 37
268 OROPHARYNGEAL PAIN 37
269 RENAL IMPAIRMENT 37
270 TREATMENT NONCOMPLIANCE 37
271 INJECTION SITE PRURITUS 36
272 THROAT IRRITATION 36
273 BONE PAIN 35
274 BREAST CANCER STAGE II 35
275 CEREBROVASCULAR ACCIDENT 35
276 PLEURAL EFFUSION 35
277 SKIN DISORDER 35
278 AGITATION 34
279 ANAPHYLACTIC REACTION 34
280 BREAST OPERATION 34
281 CARDIAC FAILURE 34
282 HEART RATE INCREASED 34
283 HYPERHIDROSIS 34
284 INCORRECT DOSE ADMINISTERED 34
285 SKIN EXFOLIATION 34
286 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 34
287 BREAST CANCER 33
288 INJECTION RELATED REACTION 33
289 NEOPLASM PROGRESSION 33
290 DYSPHONIA 32
291 INFLUENZA LIKE ILLNESS 32
292 MUCOSAL INFLAMMATION 32
293 NAIL DISORDER 32
294 PRODUCT ADMINISTRATION ERROR 32
295 RENAL FAILURE 32
296 AGEUSIA 31
297 DEEP VEIN THROMBOSIS 31
298 DIPLOPIA 31
299 PSORIASIS 31
300 ALANINE AMINOTRANSFERASE INCREASED 30
301 CYTOPENIA 30
302 HOT FLUSH 30
303 LYMPHADENOPATHY 30
304 PARONYCHIA 30
305 PNEUMONITIS 30
306 SEIZURE 30
307 THERAPY CHANGE 30
308 THERAPY INTERRUPTED 30
309 THROMBOSIS 30
310 ADMINISTRATION RELATED REACTION 29
311 ASPARTATE AMINOTRANSFERASE INCREASED 29
312 LIVER FUNCTION TEST INCREASED 29
313 METASTASES TO BONE 29
314 PANCYTOPENIA 29
315 SWELLING FACE 29
316 BLEPHAROSPASM 28
317 BLOOD POTASSIUM DECREASED 28
318 CONJUNCTIVAL OEDEMA 28
319 DYSGEUSIA 28
320 PRODUCT PRESCRIBING ERROR 28
321 VISUAL ACUITY REDUCED 28
322 ASCITES 27
323 COLITIS 27
324 DRUG-INDUCED LIVER INJURY 27
325 DYSARTHRIA 27
326 EYE PAIN 27
327 EYELID PTOSIS 27
328 PAROPHTHALMIA 27
329 ADMINISTRATION SITE REACTION 26
330 DEPRESSED MOOD 26
331 HERPES ZOSTER 26
332 IRRITABILITY 26
333 MULTIPLE SCLEROSIS RELAPSE 26
334 NASAL CONGESTION 26
335 PRODUCT TEMPERATURE EXCURSION ISSUE 26
336 SENSORY DISTURBANCE 26
337 ULCER HAEMORRHAGE 26
338 VIRAL INFECTION 26
339 EPILEPSY 25
340 EXOPHTHALMOS 25
341 HYPOALBUMINAEMIA 25
342 MYASTHENIA GRAVIS CRISIS 25
343 PULMONARY EMBOLISM 25
344 ACNE 24
345 FOETAL EXPOSURE DURING PREGNANCY 24
346 HAEMORRHAGE 24
347 BACK INJURY 23
348 CARDIAC ARREST 23
349 DISABILITY 23
350 MUSCLE TWITCHING 23
351 BLOOD BILIRUBIN INCREASED 22
352 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 22
353 DRY EYE 22
354 EYE SWELLING 22
355 HYPONATRAEMIA 22
356 MYOCARDIAL INFARCTION 22
357 ONYCHOMADESIS 22
358 ADRENAL INSUFFICIENCY 21
359 BLOOD ALKALINE PHOSPHATASE INCREASED 21
360 CEREBRAL HAEMORRHAGE 21
361 CYTOKINE RELEASE SYNDROME 21
362 LAGOPHTHALMOS 21
363 MOUTH ULCERATION 21
364 RED BLOOD CELL COUNT DECREASED 21
365 THERAPEUTIC RESPONSE DECREASED 21
366 BLOOD UREA INCREASED 20
367 INJECTION SITE DISCOMFORT 20
368 INTERCEPTED MEDICATION ERROR 20
369 LYMPHOEDEMA 20
370 THROAT TIGHTNESS 20
371 CATARACT 19
372 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 19
373 HYPERTRANSAMINASAEMIA 19
374 INJECTION SITE DISCOLOURATION 19
375 METASTASES TO LIVER 19
376 MODIFIED RADICAL MASTECTOMY 19
377 PRESYNCOPE 19
378 PRODUCT DISPENSING ERROR 19
379 PRODUCT PREPARATION ERROR 19
380 RASH ERYTHEMATOUS 19
381 SENSORY LOSS 19
382 SEPTIC SHOCK 19
383 CLOSTRIDIUM DIFFICILE INFECTION 18
384 CRYING 18
385 DYSPNOEA EXERTIONAL 18
386 INTRAOCULAR PRESSURE INCREASED 18
387 LIMB DISCOMFORT 18
388 MASS 18
389 OCULAR HYPERAEMIA 18
390 STEM CELL TRANSPLANT 18
391 ANAESTHETIC COMPLICATION 17
392 BLINDNESS 17
393 CARDIAC DYSFUNCTION 17
394 DRUG INTERACTION 17
395 FLUID RETENTION 17
396 FULL BLOOD COUNT DECREASED 17
397 GRANULOCYTE COUNT DECREASED 17
398 HEPATIC FUNCTION ABNORMAL 17
399 HYPOXIA 17
400 INFUSION SITE REACTION 17
401 LACRIMATION INCREASED 17
402 LETHARGY 17
403 OSTEONECROSIS OF JAW 17
404 OVERDOSE 17
405 POST PROCEDURAL COMPLICATION 17
406 PROTEIN TOTAL DECREASED 17
407 RETINAL ARTERY OCCLUSION 17
408 SKIN REACTION 17
409 THERAPY CESSATION 17
410 TOXICITY TO VARIOUS AGENTS 17
411 VERTIGO 17
412 ARRHYTHMIA 16
413 AXILLARY LYMPHADENECTOMY 16
414 BREAST CONSERVING SURGERY 16
415 BREAST MASS 16
416 FEELING COLD 16
417 HYPOPHAGIA 16
418 JOINT DESTRUCTION 16
419 LYMPHOPENIA 16
420 NEURALGIA 16
421 PAIN IN JAW 16
422 POLYNEUROPATHY 16
423 PROCEDURAL HEADACHE 16
424 PRODUCT PREPARATION ISSUE 16
425 PRODUCTIVE COUGH 16
426 PURTSCHER RETINOPATHY 16
427 RENAL DISORDER 16
428 RESPIRATORY FAILURE 16
429 SYRINGE ISSUE 16
430 THERAPEUTIC RESPONSE SHORTENED 16
431 ACUTE MACULAR NEURORETINOPATHY 15
432 BLOOD PHOSPHORUS INCREASED 15
433 BREAST CANCER METASTATIC 15
434 CHOKING 15
435 DYSSTASIA 15
436 DYSURIA 15
437 ECZEMA 15
438 HAEMATOCHEZIA 15
439 HIP FRACTURE 15
440 HYPOACUSIS 15
441 MACULAR ISCHAEMIA 15
442 NEOPLASM 15
443 NERVOUS SYSTEM DISORDER 15
444 NEUTROPHIL COUNT INCREASED 15
445 PAIN OF SKIN 15
446 POLYARTHRITIS 15
447 PULMONARY OEDEMA 15
448 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, HYPERSOMNIA TYPE 15
449 SNEEZING 15
450 SPEECH DISORDER 15
451 STRESS 15
452 TRANSPLANT 15
453 ANAPHYLACTIC SHOCK 14
454 BODY TEMPERATURE INCREASED 14
455 DEVICE ISSUE 14
456 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14
457 EYELID OEDEMA 14
458 FEEDING DISORDER 14
459 FULL BLOOD COUNT ABNORMAL 14
460 HAEMORRHOIDS 14
461 HYPERNATRAEMIA 14
462 IMMUNOSUPPRESSION 14
463 MENTAL DISORDER 14
464 METABOLIC ACIDOSIS 14
465 NEEDLE ISSUE 14
466 PROCEDURAL PAIN 14
467 SKIN ATROPHY 14
468 SKIN BURNING SENSATION 14
469 THERAPY PARTIAL RESPONDER 14
470 ACCIDENTAL EXPOSURE TO PRODUCT 13
471 ANGIOEDEMA 13
472 BLOOD IMMUNOGLOBULIN G DECREASED 13
473 COGNITIVE DISORDER 13
474 DEVICE RELATED INFECTION 13
475 DIABETES MELLITUS 13
476 ESCHERICHIA INFECTION 13
477 EYE INJURY 13
478 FLATULENCE 13
479 IMMUNE SYSTEM DISORDER 13
480 INJECTION SITE WARMTH 13
481 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 13
482 MUSCLE ATROPHY 13
483 NERVE INJURY 13
484 PLASMA CELL MYELOMA RECURRENT 13
485 RECURRENT CANCER 13
486 RESPIRATORY TRACT INFECTION 13
487 STRABISMUS 13
488 SYMPTOM RECURRENCE 13
489 TACHYPNOEA 13
490 URINARY INCONTINENCE 13
491 CARDIOMYOPATHY 12
492 CATATONIA 12
493 CENTRAL NERVOUS SYSTEM LESION 12
494 DRUG TOLERANCE 12
495 HAEMATOMA 12
496 HYPOCHOLESTEROLAEMIA 12
497 INFUSION SITE PAIN 12
498 INJECTION SITE HAEMORRHAGE 12
499 METASTATIC NEOPLASM 12
500 MULTIPLE SCLEROSIS 12
501 MYOSITIS 12
502 NAIL DISCOLOURATION 12
503 PALLOR 12
504 RESPIRATORY DISTRESS 12
505 SERONEGATIVE ARTHRITIS 12
506 SKIN LAXITY 12
507 TEMPERATURE INTOLERANCE 12
508 TRANSIENT ISCHAEMIC ATTACK 12
509 ACCIDENTAL OVERDOSE 11
510 ADVERSE REACTION 11
511 ANGINA PECTORIS 11
512 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 11
513 BACK DISORDER 11
514 BLOOD ALBUMIN DECREASED 11
515 BREAST CANCER RECURRENT 11
516 CARDIAC FAILURE CONGESTIVE 11
517 CARDIOTOXICITY 11
518 CELLULITIS ORBITAL 11
519 CHRONIC KIDNEY DISEASE 11
520 COMA 11
521 CYSTITIS 11
522 EYE MOVEMENT DISORDER 11
523 FACIAL PARALYSIS 11
524 GOUT 11
525 HEART RATE DECREASED 11
526 HEPATITIS 11
527 HICCUPS 11
528 HYPOAESTHESIA ORAL 11
529 INJECTION SITE DISCHARGE 11
530 LIMB INJURY 11
531 METASTASES TO LUNG 11
532 OSTEOPENIA 11
533 PRODUCT COMPLAINT 11
534 PULMONARY HYPERTENSION 11
535 STAPHYLOCOCCAL INFECTION 11
536 SUPRAVENTRICULAR TACHYCARDIA 11
537 TINNITUS 11
538 COELIAC DISEASE 10
539 DERMATITIS ACNEIFORM 10
540 DISORIENTATION 10
541 DIVERTICULITIS 10
542 EYE DISORDER 10
543 GENERALISED TONIC-CLONIC SEIZURE 10
544 GINGIVAL SWELLING 10
545 HEPATIC CYTOLYSIS 10
546 HYPERGLYCAEMIA 10
547 INSURANCE ISSUE 10
548 INTENTIONAL PRODUCT MISUSE 10
549 LIVER FUNCTION TEST ABNORMAL 10
550 LOCALISED INFECTION 10
551 MOVEMENT DISORDER 10
552 MYOPATHY TOXIC 10
553 ORBITAL OEDEMA 10
554 PARAESTHESIA ORAL 10
555 POOR VENOUS ACCESS 10
556 PRODUCT LABEL CONFUSION 10
557 RASH MACULAR 10
558 RETINAL DETACHMENT 10
559 SARS-COV-2 TEST POSITIVE 10
560 SKIN INFECTION 10
561 SPINAL FUSION SURGERY 10
562 UNEVALUABLE EVENT 10
563 VASCULAR DEVICE INFECTION 10
564 ABDOMINAL PAIN LOWER 9
565 ADMINISTRATION SITE SWELLING 9
566 ANTIPHOSPHOLIPID ANTIBODIES 9
567 ASPIRATION 9
568 BLOOD SODIUM DECREASED 9
569 BRADYCARDIA 9
570 BREAST NEOPLASM 9
571 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9
572 CORONARY ARTERY DISEASE 9
573 DERMATITIS 9
574 DEVICE DIFFICULT TO USE 9
575 GASTROINTESTINAL HAEMORRHAGE 9
576 HAEMATOCRIT DECREASED 9
577 HEAD INJURY 9
578 HYPOVOLAEMIC SHOCK 9
579 INFUSION SITE ERYTHEMA 9
580 INFUSION SITE PRURITUS 9
581 INFUSION SITE SWELLING 9
582 INVASIVE DUCTAL BREAST CARCINOMA 9
583 LIP SWELLING 9
584 LOCAL REACTION 9
585 METASTASES TO LYMPH NODES 9
586 MYDRIASIS 9
587 NEUROTOXICITY 9
588 ONYCHOCLASIS 9
589 OPTIC ATROPHY 9
590 ORAL DISCOMFORT 9
591 PHOTOSENSITIVITY REACTION 9
592 PNEUMOTHORAX 9
593 SCAR 9
594 SEASONAL ALLERGY 9
595 SKIN ULCER 9
596 SWOLLEN TONGUE 9
597 TENDER JOINT COUNT 9
598 ULCER 9
599 APHONIA 8
600 ASPARTATE AMINOTRANSFERASE ABNORMAL 8
601 BONE DISORDER 8
602 BONE LESION 8
603 CLOSTRIDIUM DIFFICILE COLITIS 8
604 COLD SWEAT 8
605 DEFORMITY 8
606 DEVICE BREAKAGE 8
607 DILATED CARDIOMYOPATHY 8
608 DRUG RESISTANCE 8
609 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8
610 FRACTURE 8
611 GASTROENTERITIS 8
612 HEART RATE IRREGULAR 8
613 IMPAIRED QUALITY OF LIFE 8
614 INDURATION 8
615 INJECTION SITE EXTRAVASATION 8
616 INJECTION SITE URTICARIA 8
617 INJECTION SITE VESICLES 8
618 INTERCEPTED PRODUCT PREPARATION ERROR 8
619 LEUKOCYTOSIS 8
620 LYMPHOCYTE COUNT DECREASED 8
621 MELAENA 8
622 METASTASIS 8
623 MUSCLE SPASTICITY 8
624 MUSCULOSKELETAL CHEST PAIN 8
625 PHARYNGEAL SWELLING 8
626 PHYSICAL DECONDITIONING 8
627 PNEUMONIA BACTERIAL 8
628 POLLAKIURIA 8
629 PRODUCT STORAGE ISSUE 8
630 RASH VESICULAR 8
631 RESTLESSNESS 8
632 SCAB 8
633 SENSITIVE SKIN 8
634 SKIN LESION 8
635 SPINAL PAIN 8
636 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 8
637 SUSPECTED OFF LABEL USE 8
638 TOOTHACHE 8
639 UNRESPONSIVE TO STIMULI 8
640 URINARY RETENTION 8
641 ABDOMINAL TENDERNESS 7
642 ACUTE MYOCARDIAL INFARCTION 7
643 ACUTE RESPIRATORY DISTRESS SYNDROME 7
644 ADMINISTRATION SITE ERYTHEMA 7
645 BACTERIAL INFECTION 7
646 BLOOD CALCIUM DECREASED 7
647 BLOOD POTASSIUM INCREASED 7
648 BLOOD PRESSURE FLUCTUATION 7
649 BLOOD TEST ABNORMAL 7
650 BREAST DISORDER 7
651 BRONCHOSPASM 7
652 CARDIO-RESPIRATORY ARREST 7
653 CARDIOMEGALY 7
654 COVID-19 PNEUMONIA 7
655 DEPRESSED LEVEL OF CONSCIOUSNESS 7
656 DERMATITIS ALLERGIC 7
657 EATING DISORDER 7
658 ELECTROCARDIOGRAM T WAVE AMPLITUDE INCREASED 7
659 GENERALISED OEDEMA 7
660 HAEMATOTOXICITY 7
661 HALLUCINATION 7
662 HEPATIC CANCER 7
663 HEPATOTOXICITY 7
664 HORDEOLUM 7
665 HYPERKALAEMIA 7
666 HYPERPYREXIA 7
667 HYPOCALCAEMIA 7
668 INJECTION SITE IRRITATION 7
669 INJECTION SITE MASS 7
670 KIDNEY INFECTION 7
671 LACTIC ACIDOSIS 7
672 LIGHT CHAIN ANALYSIS INCREASED 7
673 LIQUID PRODUCT PHYSICAL ISSUE 7
674 MASTICATION DISORDER 7
675 MOTOR DYSFUNCTION 7
676 NEPHROLITHIASIS 7
677 NORMAL NEWBORN 7
678 OPEN GLOBE INJURY 7
679 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7
680 PHARYNGITIS 7
681 PHOTOPHOBIA 7
682 POLYNEUROPATHY CHRONIC 7
683 PRODUCT CONTAINER ISSUE 7
684 PRODUCT DOSE OMISSION IN ERROR 7
685 PULMONARY CONGESTION 7
686 PULMONARY TOXICITY 7
687 PUSTULAR PSORIASIS 7
688 RESPIRATORY SYNCYTIAL VIRUS INFECTION 7
689 SINUS DISORDER 7
690 SPONDYLITIS 7
691 STRESS CARDIOMYOPATHY 7
692 THERMAL BURN 7
693 THROMBOTIC MICROANGIOPATHY 7
694 TOOTH DISORDER 7
695 TRANSAMINASES INCREASED 7
696 ACQUIRED PORPHYRIA 6
697 ACUTE RESPIRATORY FAILURE 6
698 AGRANULOCYTOSIS 6
699 APHTHOUS ULCER 6
700 BEDRIDDEN 6
701 BLOOD MAGNESIUM DECREASED 6
702 BLOOD PHOSPHORUS DECREASED 6
703 BRAIN NEOPLASM 6
704 BREAST PAIN 6
705 CARDIAC FAILURE ACUTE 6
706 CEREBRAL DISORDER 6
707 CEREBRAL INFARCTION 6
708 CONJUNCTIVAL HAEMORRHAGE 6
709 CONJUNCTIVITIS 6
710 DEVICE MALFUNCTION 6
711 DIABETIC KETOACIDOSIS 6
712 DISEASE RECURRENCE 6
713 DISTURBANCE IN ATTENTION 6
714 DRUG ADMINISTERED AT INAPPROPRIATE SITE 6
715 DRUG EFFECT LESS THAN EXPECTED 6
716 ENTERITIS 6
717 EXPIRED PRODUCT ADMINISTERED 6
718 EXTRA DOSE ADMINISTERED 6
719 EYE IRRITATION 6
720 EYE PRURITUS 6
721 FLANK PAIN 6
722 FUNGAL INFECTION 6
723 FURUNCLE 6
724 GASTRITIS 6
725 GASTROENTERITIS VIRAL 6
726 GASTROINTESTINAL INFECTION 6
727 HAEMORRHAGE SUBCUTANEOUS 6
728 HEAD DISCOMFORT 6
729 HEPATIC FAILURE 6
730 HERNIA 6
731 HYPOMAGNESAEMIA 6
732 HYPOTHYROIDISM 6
733 INCONTINENCE 6
734 INJECTION SITE INDURATION 6
735 INTENTIONAL DOSE OMISSION 6
736 INTRAOCULAR PRESSURE FLUCTUATION 6
737 IRIDOCYCLITIS 6
738 IRON DEFICIENCY ANAEMIA 6
739 LEFT VENTRICULAR DYSFUNCTION 6
740 LICHEN PLANUS 6
741 LUNG NEOPLASM MALIGNANT 6
742 LYMPHOMA 6
743 MALNUTRITION 6
744 MENINGITIS 6
745 MENTAL IMPAIRMENT 6
746 METASTASES TO SPINE 6
747 MUSCLE FATIGUE 6
748 MUSCULOSKELETAL DISCOMFORT 6
749 MYOCARDITIS 6
750 NEUTROPHIL COUNT ABNORMAL 6
751 OCULAR DISCOMFORT 6
752 OPHTHALMOPLEGIA 6
753 OPTIC NERVE DISORDER 6
754 OPTIC NEURITIS 6
755 PANIC ATTACK 6
756 PAPILLOEDEMA 6
757 PERFORMANCE STATUS DECREASED 6
758 PERIORBITAL OEDEMA 6
759 PERIORBITAL SWELLING 6
760 PERONEAL NERVE PALSY 6
761 PNEUMOCYSTIS JIROVECII PNEUMONIA 6
762 PRODUCT DISTRIBUTION ISSUE 6
763 PRODUCT LEAKAGE 6
764 RESPIRATORY SYMPTOM 6
765 RESPIRATORY TRACT CONGESTION 6
766 RETINAL HAEMORRHAGE 6
767 SINUS CONGESTION 6
768 SKIN IRRITATION 6
769 SKIN TOXICITY 6
770 SKIN WRINKLING 6
771 STEVENS-JOHNSON SYNDROME 6
772 THYROID DISORDER 6
773 TOXIC ANTERIOR SEGMENT SYNDROME 6
774 TUMOUR LYSIS SYNDROME 6
775 UPPER-AIRWAY COUGH SYNDROME 6
776 VITREOUS HAEMORRHAGE 6
777 ANOSMIA 5
778 APNOEA 5
779 AXILLARY VEIN THROMBOSIS 5
780 BLADDER DISORDER 5
781 BLOOD CALCIUM INCREASED 5
782 BLOOD PRESSURE SYSTOLIC DECREASED 5
783 BLOOD URINE PRESENT 5
784 BONE MARROW TRANSPLANT 5
785 BRAIN INJURY 5
786 CAUDA EQUINA SYNDROME 5
787 CELLULITE 5
788 COMPRESSION FRACTURE 5
789 CYTOMEGALOVIRUS INFECTION 5
790 DEAFNESS 5
791 DIFFUSE ALVEOLAR DAMAGE 5
792 DYSPNOEA AT REST 5
793 EAR DISCOMFORT 5
794 EAR PRURITUS 5
795 EMBOLISM VENOUS 5
796 ENTEROCOLITIS 5
797 EYE HAEMORRHAGE 5
798 FACE INJURY 5
799 FACIAL PAIN 5
800 FAECES SOFT 5
801 FEELING JITTERY 5
802 FINGER DEFORMITY 5
803 FUNCTIONAL GASTROINTESTINAL DISORDER 5
804 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5
805 GINGIVAL BLEEDING 5
806 GLOMERULAR FILTRATION RATE DECREASED 5
807 HAEMATOLOGICAL INFECTION 5
808 HAEMOGLOBIN ABNORMAL 5
809 HAEMOGLOBIN INCREASED 5
810 HAEMOPTYSIS 5
811 HEART FAILURE WITH REDUCED EJECTION FRACTION 5
812 HYPOGAMMAGLOBULINAEMIA 5
813 HYPOGLYCAEMIA 5
814 IMMUNOGLOBULINS DECREASED 5
815 INCORRECT DRUG ADMINISTRATION RATE 5
816 INCORRECT ROUTE OF DRUG ADMINISTRATION 5
817 INTERCEPTED PRODUCT ADMINISTRATION ERROR 5
818 INTESTINAL OBSTRUCTION 5
819 INVESTIGATION ABNORMAL 5
820 ISCHAEMIC STROKE 5
821 LID SULCUS DEEPENED 5
822 LIGHT CHAIN ANALYSIS ABNORMAL 5
823 LYMPHADENECTOMY 5
824 MATERNAL EXPOSURE BEFORE PREGNANCY 5
825 MENTAL STATUS CHANGES 5
826 METASTASES TO SKIN 5
827 MOOD SWINGS 5
828 MULTIPLE ORGAN DYSFUNCTION SYNDROME 5
829 MUSCLE DISORDER 5
830 MUSCLE TIGHTNESS 5
831 NAIL INFECTION 5
832 NERVE COMPRESSION 5
833 NODULE 5
834 NONSPECIFIC REACTION 5
835 ONYCHOMYCOSIS 5
836 OPTIC NEUROPATHY 5
837 ORAL FUNGAL INFECTION 5
838 OSTEOMYELITIS 5
839 PELVIC PAIN 5
840 PERIPHERAL SENSORY NEUROPATHY 5
841 PIGMENTATION DISORDER 5
842 PLASMA CELL MYELOMA REFRACTORY 5
843 PLATELET DISORDER 5
844 PNEUMONIA ASPIRATION 5
845 POSTOPERATIVE WOUND INFECTION 5
846 PRODUCT CLOSURE ISSUE 5
847 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 5
848 PRODUCT PACKAGING CONFUSION 5
849 PRODUCT PRESCRIBING ISSUE 5
850 PROSTATE CANCER 5
851 PROTEIN TOTAL INCREASED 5
852 PULMONARY MASS 5
853 RENAL PAIN 5
854 RHABDOMYOLYSIS 5
855 SKIN ABRASION 5
856 SKIN MASS 5
857 SKIN SWELLING 5
858 SKIN TEXTURE ABNORMAL 5
859 SKIN TIGHTNESS 5
860 SPINAL DISORDER 5
861 SPINAL FRACTURE 5
862 SPINAL OPERATION 5
863 TENDERNESS 5
864 THERAPEUTIC PRODUCT EFFECT DELAYED 5
865 THERAPEUTIC RESPONSE UNEXPECTED 5
866 TOOTH EXTRACTION 5
867 TRANSFUSION 5
868 TROPONIN INCREASED 5
869 TUMOUR MARKER INCREASED 5
870 URINE OUTPUT DECREASED 5
871 VENOUS THROMBOSIS LIMB 5
872 VISUAL FIELD DEFECT 5
873 VITAMIN D DEFICIENCY 5
874 ABDOMINAL ABSCESS 4
875 ACUTE HEPATIC FAILURE 4
876 AMYLASE INCREASED 4
877 ANAESTHETIC COMPLICATION NEUROLOGICAL 4
878 ANAL INCONTINENCE 4
879 APPLICATION SITE ERYTHEMA 4
880 APPLICATION SITE REACTION 4
881 BLOOD PRESSURE SYSTOLIC INCREASED 4
882 BODY TEMPERATURE DECREASED 4
883 CANDIDA INFECTION 4
884 CARDIAC DISCOMFORT 4
885 CARDIOGENIC SHOCK 4
886 CARDIOVASCULAR DISORDER 4
887 CIRCULATORY COLLAPSE 4
888 COLITIS MICROSCOPIC 4
889 CONCOMITANT DISEASE AGGRAVATED 4
890 CONVULSION 4
891 COORDINATION ABNORMAL 4
892 CYST 4
893 DEATH NEONATAL 4
894 DEMENTIA 4
895 DEMENTIA ALZHEIMER^S TYPE 4
896 DENGUE FEVER 4
897 DEVICE DISLOCATION 4
898 DEVICE USE ERROR 4
899 DRUG ERUPTION 4
900 DRUG MONITORING PROCEDURE NOT PERFORMED 4
901 DRY THROAT 4
902 DYSKINESIA 4
903 ECCHYMOSIS 4
904 EMOTIONAL DISTRESS 4
905 ENCEPHALITIS 4
906 EOSINOPHILIA 4
907 EPIGASTRIC DISCOMFORT 4
908 ERYTHEMA MULTIFORME 4
909 EYE DISCHARGE 4
910 EYE INFLAMMATION 4
911 EYELID DISORDER 4
912 FACIAL WASTING 4
913 FEAR OF INJECTION 4
914 FEMUR FRACTURE 4
915 FOREIGN BODY IN EYE 4
916 FUNGAL SKIN INFECTION 4
917 GASTRIC INFECTION 4
918 GASTRIC ULCER 4
919 GASTROINTESTINAL PAIN 4
920 GENERAL SYMPTOM 4
921 GINGIVAL RECESSION 4
922 GROIN PAIN 4
923 HAEMATURIA 4
924 HAIR TEXTURE ABNORMAL 4
925 HER2 POSITIVE BREAST CANCER 4
926 HYPERCHLORHYDRIA 4
927 HYPERLIPIDAEMIA 4
928 HYPERSOMNIA 4
929 HYPOKINESIA 4
930 HYPOPNOEA 4
931 IATROGENIC INJURY 4
932 IMPAIRED WORK ABILITY 4
933 INCORRECT DOSE ADMINISTERED BY DEVICE 4
934 INCREASED TENDENCY TO BRUISE 4
935 INFUSION SITE BRUISING 4
936 INFUSION SITE EXTRAVASATION 4
937 INITIAL INSOMNIA 4
938 INJECTION SITE EXFOLIATION 4
939 INJECTION SITE HAEMATOMA 4
940 INJECTION SITE INFLAMMATION 4
941 INTERCEPTED PRODUCT SELECTION ERROR 4
942 INVASIVE BREAST CARCINOMA 4
943 IRON DEFICIENCY 4
944 JOINT INJURY 4
945 JOINT INSTABILITY 4
946 KLEBSIELLA INFECTION 4
947 LOWER RESPIRATORY TRACT CONGESTION 4
948 LYMPHADENOPATHY MEDIASTINAL 4
949 MENISCUS INJURY 4
950 METASTATIC LYMPHOMA 4
951 MITRAL VALVE INCOMPETENCE 4
952 MUSCLE STRAIN 4
953 MUSCLE SWELLING 4
954 MYELODYSPLASTIC SYNDROME 4
955 NASAL DRYNESS 4
956 NEPHROTIC SYNDROME 4
957 NERVOUSNESS 4
958 NODULAR REGENERATIVE HYPERPLASIA 4
959 ONYCHALGIA 4
960 OPTIC ISCHAEMIC NEUROPATHY 4
961 OPTIC NERVE INJURY 4
962 ORAL DISORDER 4
963 ORAL PAIN 4
964 ORGANISING PNEUMONIA 4
965 OROPHARYNGEAL DISCOMFORT 4
966 OSTEONECROSIS 4
967 PANCREATITIS ACUTE 4
968 PERICARDIAL EFFUSION 4
969 PHARYNGEAL ULCERATION 4
970 PNEUMONIA VIRAL 4
971 POOR QUALITY PRODUCT ADMINISTERED 4
972 PROCEDURAL DIZZINESS 4
973 PROCEDURAL NAUSEA 4
974 PRODUCT LABEL ISSUE 4
975 PRODUCT PACKAGING ISSUE 4
976 PYELONEPHRITIS 4
977 QUALITY OF LIFE DECREASED 4
978 RASH MACULO-PAPULAR 4
979 REBOUND EFFECT 4
980 RECTAL CANCER 4
981 REHABILITATION THERAPY 4
982 RENAL FUNCTION TEST ABNORMAL 4
983 RHINALGIA 4
984 SCRATCH 4
985 SEDATION 4
986 SHOCK 4
987 SKIN WARM 4
988 SLUGGISHNESS 4
989 SMALL INTESTINAL OBSTRUCTION 4
990 SQUAMOUS CELL CARCINOMA 4
991 SWELLING OF EYELID 4
992 THIRST 4
993 TONGUE DISCOLOURATION 4
994 TOOTH ABSCESS 4
995 TYPE IV HYPERSENSITIVITY REACTION 4
996 UPPER LIMB FRACTURE 4
997 VAGINAL HAEMORRHAGE 4
998 VASCULAR OCCLUSION 4
999 VENTRICULAR TACHYCARDIA 4